Iga nephropathy and Drowsiness

Summary:

Drowsiness is found among people with Iga nephropathy, especially for people who are male, 60+ old.

The study analyzes which people have Drowsiness with Iga nephropathy. It is created by eHealthMe based on reports of 91 people who have Iga nephropathy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Iga nephropathy?

Iga nephropathy (kidney disease- condition prevents the kidneys from filtering waste) is found to be associated with 91 drugs and 424 conditions by eHealthMe. Check the latest studies of Iga nephropathy.

What is Drowsiness?

Drowsiness is found to be associated with 2,863 drugs and 4,800 conditions by eHealthMe. Check the latest studies of Drowsiness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 04, 2026

91 people who have Iga Nephropathy and Drowsiness are studied.

Would you have Drowsiness when you have Iga nephropathy?

Gender of people who have Iga Nephropathy and experienced Drowsiness *:

female: 45.05 %
male: 54.95 %

Age of people who have Iga Nephropathy and experienced Drowsiness *:

Common co-existing conditions for these people *:

Chronic Kidney Disease: 9 people, 9.89%
Haematuria (presence of blood in urine): 8 people, 8.79%
Gastric Cancer (stomach cancer): 3 people, 3.30%
Peripheral Swelling: 1 person, 1.10%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 1 person, 1.10%
High Blood Pressure: 1 person, 1.10%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 1 person, 1.10%

Common drugs taken by these people *:

Tarpeyo: 46 people, 50.55%
Filspari: 45 people, 49.45%
Farxiga: 14 people, 15.38%
Fish Oil: 6 people, 6.59%
Lisinopril: 5 people, 5.49%
Prednisone: 4 people, 4.40%
Allopurinol: 4 people, 4.40%
Vitamin D3: 4 people, 4.40%
Losartan: 4 people, 4.40%
Granisetron Hydrochloride: 3 people, 3.30%

Common symptoms for these people *:

Fatigue (feeling of tiredness): 46 people, 50.55%
Dizziness: 22 people, 24.18%
High Blood Pressure: 11 people, 12.09%
Hypotension (abnormally low blood pressure): 11 people, 12.09%
Nausea (feeling of having an urge to vomit): 10 people, 10.99%
Peripheral Swelling: 10 people, 10.99%
Insomnia (sleeplessness): 8 people, 8.79%
Diarrhea: 8 people, 8.79%
Weakness: 7 people, 7.69%
Headache (pain in head): 7 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Iga nephropathy (5,130 reports)
Drowsiness (269,040 reports)

All the drugs that are associated with Drowsiness:

Drowsiness (2,863 drugs)

All the conditions that are associated with Drowsiness:

Drowsiness (4,800 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Drowsiness and Iga nephropathy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.